Nasdaq · CIK 0001671584
APVO Aptevo Therapeutics Inc.
Insider trading from SEC Form 4. Last filing Aug 10, 2026. Close $1.79 on Oct 9, 2026, +5% from the 52-week low and -94% from the high.
In brief
Aptevo Therapeutics Inc. (APVO) has 35 SEC Form 4 filings on file from 10 insiders, the latest filed on Aug 10, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 open-market trade has been scored at APVO. The newest: Grady Grant III (director) bought $20k of stock on Nov 10, 2025, filed Nov 12, 2025, scored 25 (weak).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Aptevo Therapeutics Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Grady Grant III director buy | $20k 13,513 shares | first purchase | - |
Transactions
The newest 50 of 69 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Dirk Huebner SVP, CMO | MOption exercise Common Stock | +638 | - | - | 638 | Aug 10, 2026 |
| Aug 6, 2026 | Daphne Taylor SVP, CFO | MOption exercise Common Stock | +638 | - | - | 638 | Aug 10, 2026 |
| Aug 6, 2026 | Jeffrey G. Lamothe President and CEO | MOption exercise Common Stock | +961 | - | - | 961 | Aug 10, 2026 |
| Aug 6, 2026 | Daniel Abdun-Nabi director | MOption exercise Common Stock | +400 | - | - | 400 | Aug 10, 2026 |
| Aug 6, 2026 | Barbara Lopez Kunz director | MOption exercise Common Stock | +400 | - | - | 400 | Aug 10, 2026 |
| Aug 6, 2026 | SoYoung Kwon SVP, GC, BD & Corp Affairs | MOption exercise Common Stock | +638 | - | - | 638 | Aug 10, 2026 |
| Aug 6, 2026 | Zsolt Harsanyi director | MOption exercise Common Stock | +400 | - | - | 400 | Aug 10, 2026 |
| Aug 6, 2026 | John Niederhuber director | MOption exercise Common Stock | +400 | - | - | 400 | Aug 10, 2026 |
| Aug 6, 2026 | Grady Grant III director | MOption exercise Common Stock | +400 | - | - | 1,150 | Aug 10, 2026 |
| Jul 17, 2026 | Marvin L White Executive Chair | MOption exercise Common Stock | +1 | - | - | 1 | Aug 10, 2026 |
| Aug 6, 2026 | SoYoung Kwon SVP, GC, BD & Corp Affairs | MOption exercise Restricted Stock Unitderivative | -638 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2026 | Daphne Taylor SVP, CFO | MOption exercise Restricted Stock Unitderivative | -638 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2026 | Barbara Lopez Kunz director | MOption exercise Restricted Stock Unitderivative | -400 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2026 | Zsolt Harsanyi director | MOption exercise Restricted Stock Unitderivative | -400 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2026 | Daniel Abdun-Nabi director | MOption exercise Restricted Stock Unitderivative | -400 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2026 | Grady Grant III director | MOption exercise Restricted Stock Unitderivative | -400 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2026 | Jeffrey G. Lamothe President and CEO | MOption exercise Restricted Stock Unitderivative | -961 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2026 | Dirk Huebner SVP, CMO | FTax withholding Common Stock | -156 | $4.07 | $635 | 482 | Aug 10, 2026 |
| Aug 6, 2026 | John Niederhuber director | MOption exercise Restricted Stock Unitderivative | -400 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2026 | Marvin L White Executive Chair | MOption exercise Common Stock | +1,666 | - | - | 1,667 | Aug 10, 2026 |
| Aug 6, 2026 | Marvin L White Executive Chair | FTax withholding Common Stock | -406 | $4.07 | $1,652 | 1,261 | Aug 10, 2026 |
| Aug 6, 2026 | Dirk Huebner SVP, CMO | MOption exercise Restricted Stock Unitderivative | -638 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Jul 17, 2026 | Marvin L White Executive Chair | MOption exercise Restricted Stock Unitderivative | -1 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2026 | Marvin L White Executive Chair | MOption exercise Restricted Stock Unitderivative | -1,666 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Nov 10, 2025 | Grady Grant III director | POpen-market purchase Common Stock | +13,513 | $1.49 | $20k | 13,514 | Nov 12, 2025 |
| Aug 6, 2025 | John Niederhuber director | AGrant or award Restricted Stock Unitderivative | +7,200 | $0.00 | $0 | 7,200 | Aug 8, 2025 |
| Aug 6, 2025 | Dirk Huebner SVP, CMO | AGrant or award Restricted Stock Unitderivative | +11,500 | $0.00 | $0 | 11,500 | Aug 8, 2025 |
| Aug 6, 2025 | Grady Grant III director | AGrant or award Restricted Stock Unitderivative | +7,200 | $0.00 | $0 | 7,200 | Aug 8, 2025 |
| Aug 6, 2025 | Daphne Taylor SVP, CFO | AGrant or award Restricted Stock Unitderivative | +11,500 | $0.00 | $0 | 11,500 | Aug 8, 2025 |
| Aug 6, 2025 | Daniel Abdun-Nabi director | AGrant or award Restricted Stock Unitderivative | +7,200 | $0.00 | $0 | 7,200 | Aug 8, 2025 |
| Aug 6, 2025 | Zsolt Harsanyi director | AGrant or award Restricted Stock Unitderivative | +7,200 | $0.00 | $0 | 7,200 | Aug 8, 2025 |
| Aug 6, 2025 | SoYoung Kwon SVP, GC, BD & Corp Affairs | AGrant or award Restricted Stock Unitderivative | +11,500 | $0.00 | $0 | 11,500 | Aug 8, 2025 |
| Aug 6, 2025 | Barbara Lopez Kunz director | AGrant or award Restricted Stock Unitderivative | +7,200 | $0.00 | $0 | 7,200 | Aug 8, 2025 |
| Aug 6, 2025 | Marvin L White President and CEO | AGrant or award Restricted Stock Unitderivative | +30,000 | $0.00 | $0 | 30,000 | Aug 8, 2025 |
| Aug 6, 2025 | Jeffrey G. Lamothe EVP, COO | AGrant or award Restricted Stock Unitderivative | +17,300 | $0.00 | $0 | 17,300 | Aug 8, 2025 |
| Jul 17, 2025 | Daniel Abdun-Nabi director | MOption exercise Common Stock | +1 | - | - | 1 | Jul 21, 2025 |
| Jul 17, 2025 | Jeffrey G. Lamothe EVP, COO | MOption exercise Common Stock (post-reverse split May ACTIVE) | +5 | - | - | 6 | Jul 21, 2025 |
| Jul 17, 2025 | Marvin L White President and CEO | MOption exercise Common Stock | +10 | - | - | 12 | Jul 21, 2025 |
| Jul 17, 2025 | SoYoung Kwon SVP, GC, BD & Corp Affairs | MOption exercise Common Stock | +3 | - | - | 4 | Jul 21, 2025 |
| Jul 17, 2025 | Daphne Taylor SVP, CFO | MOption exercise Common Stock | +3 | - | - | 3 | Jul 21, 2025 |
| Jul 17, 2025 | John Niederhuber director | MOption exercise Common Stock | +1 | - | - | 1 | Jul 21, 2025 |
| Jul 17, 2025 | Zsolt Harsanyi director | MOption exercise Common Stock | +1 | - | - | 1 | Jul 21, 2025 |
| Jul 17, 2025 | Grady Grant III director | MOption exercise Common Stock | +1 | - | - | 1 | Jul 21, 2025 |
| Jul 17, 2025 | Barbara Lopez Kunz director | MOption exercise Common Stock | +1 | - | - | 1 | Jul 21, 2025 |
| Jul 17, 2025 | Daniel Abdun-Nabi director | MOption exercise Restricted Stock Unitderivative | -1 | $0.00 | $0 | 0 | Jul 21, 2025 |
| Jul 17, 2025 | Jeffrey G. Lamothe EVP, COO | MOption exercise Restricted Stock Unitderivative | -5 | $0.00 | $0 | 12 | Jul 21, 2025 |
| Jul 17, 2025 | Marvin L White President and CEO | MOption exercise Restricted Stock Unitderivative | -10 | $0.00 | $0 | 20 | Jul 21, 2025 |
| Jul 17, 2025 | SoYoung Kwon SVP, GC, BD & Corp Affairs | MOption exercise Restricted Stock Unitderivative | -3 | $0.00 | $0 | 8 | Jul 21, 2025 |
| Jul 17, 2025 | Daphne Taylor SVP, CFO | MOption exercise Restricted Stock Unitderivative | -3 | $0.00 | $0 | 8 | Jul 21, 2025 |
| Jul 17, 2025 | John Niederhuber director | MOption exercise Restricted Stock Unitderivative | -1 | $0.00 | $0 | 0 | Jul 21, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Daniel Abdun-Nabidirector
- Grady Grant IIIdirector
- Zsolt Harsanyichair, officer, director
- Dirk HuebnerSVP, CMO
- Barbara Lopez Kunzdirector
- SoYoung KwonSVP, GC, BD & Corp Affairs
- Jeffrey G. LamothePresident and CEO
- John Niederhuberdirector
- Daphne TaylorSVP, CFO
- Marvin L WhiteExecutive Chair
Questions about APVO
Answered from the filings on this page, as of the latest one.
Are insiders buying APVO?
No. In the last 90 days no insider at Aptevo Therapeutics Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade APVO on the open market?
Grady Grant III (director) bought $20k of APVO on Nov 10, 2025 and filed the Form 4 on Nov 12, 2025. InsiderTell scored 25 (weak).
How many insiders file Form 4 at Aptevo Therapeutics Inc.?
10 people have filed a Form 4 at Aptevo Therapeutics Inc., among them Daniel Abdun-Nabi (director), Grady Grant III (director), Zsolt Harsanyi (chair and director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.